摘要
目的:研究心脑血管疾病治疗中活血化瘀药物的作用。方法:2018年1月-2020年1月收治心脑血管疾病患者116例,随机分为两组,各58例。对照组选用化学降脂类药物治疗;研究组选用活血化瘀药物治疗。比较两组临床疗效及不良反应情况。结果:研究组治疗总有效率高于对照组,且不良反应发生率低于对照组,差异有统计学意义(P<0.05)。结论:心脑血管疾病治疗中活血化瘀药物具有显著效果,且不良反应少。
Objective:To study the effect of the drugs of activating blood circulation and removing blood stasis in the treatment of cardiovascular and cerebrovascular diseases.Methods:From January 2018 to January 2020,116 cases of patients with cardiovascular and cerebrovascular diseases were enrolled,they were randomly divided into two groups with 58 cases in each group.The control group was treated with chemical lipid-lowering drugs.The study group was treated with activating blood circulation and removing blood stasis drugs.The clinical efficacy and adverse reactions of the two groups were compared.Results:The total effective rate of treatment in the study group was higher than that in the control group,the incidence of adverse reactions was lower than that of the control group,the differences were statistically significant(P<0.05).Conclusion:The drugs of promoting blood circulation and removing blood stasis in the treatment of cardiovascular and cerebrovascular diseases have remarkable effect and less adverse reactions.
作者
黄延平
张旭雅
Huang Yanping;Zhang Xuya(Department of Internal Medicine,the Second People's Hospital of Futian District,Shenzhen City,Guangdong Shenzhen 518049;Hemodialysis Room,Shenzhen Hospital,University of Hong Kong,Guangdong Shenzhen 518000)
出处
《中国社区医师》
2021年第14期106-107,共2页
Chinese Community Doctors
关键词
心脑血管疾病
活血化瘀药物
不良反应
化学降脂类药物
疗效
Cardiovascular and cerebrovascular diseases
Drugs for promoting blood circulation and removing blood stasis
Adverse reactions
Chemical lipid-lowering drugs
Efficacy